首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Annals Of Hematology

Annals Of Hematology杂志,由Springer Berlin Heidelberg出版,于1955年创刊,Monthly,出版语言English,ISSN:0939-5555,E-ISSN:1432-0584。

投稿咨询
Annals Of Hematology
Annals Of Hematology
Annals Of Hematology
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
4区
影响因子
2.3
CiteScore
3.3
期刊收录
SCI、SCIE

Annals Of Hematology(中文译名:《血液学年鉴》),ISSN:0939-5555,EISSN:1432-0584,是Springer Berlin Heidelberg出版的国际性学术期刊,创刊于1955年,以Monthly形式稳定发行,2026年总发文量约524篇。该刊采用非OA开放访问,学科归属为医学 - 血液学。该刊是医学、血液学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.3,2025年期刊CiteScore为3.3,2025年期刊自引率约4.3%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Annals Of Hematology长期聚焦医学、血液学及相关产业的技术应用前沿,平均审稿周期约2月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、血液学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、GERMANY (FED REP GER)、Japan、Italy、Spain、France等为核心发文国家与地区;CHINESE ACADEMY OF MEDICAL SCIENCES - PEKING UNION MEDICAL COLLEGEINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、UNIVERSITY OF TEXAS SYSTEM、ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、PEKING UNIVERSITY、UNIVERSITY OF MUNICH、SAPIENZA UNIVERSITY ROME等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
HEMATOLOGY 血液学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
HEMATOLOGY 血液学
3区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
HEMATOLOGY 血液学
3区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q3 56 / 103

46.1

学科:HEMATOLOGY SCIE Q2 47 / 103

54.85

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q2 45 / 99

55.1

学科:HEMATOLOGY SCIE Q2 40 / 100

60.5


中国学者近期发文

1
Expression and prognostic impact of CD73 in classical Hodgkin lymphom

Author:Liu, Beichen; He, Cuiying; Liu, Haisheng; Ma, Guangyu; Zhang, Shuo; Liu, Yan; Liu, Caili; Li, Kexin; Wang, Yunzhe; Liu, Yueping; Yue, Meng; Liu, Chang; Wang, Xiaoxiao; Yin, Shaoning; Li, Zheng

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06987-1

2
Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrom

Author:Gao, Zhen; Yang, Fei; Pan, Hong; Zhang, Lele; Li, Weiwang; Li, Ruonan; Zhao, Jingyu; Luo, Yuechen; Yu, Xiao; Kuang, Zhexiang; Nie, Neng; Li, Jianping; Huang, Jinbo; Zhao, Xin; Ge, Meili; Zheng, Yizhou; Fang, Liwei; Shi, Jun

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-07023-y

3
PML::RARA-negative APL-mimicking AML with a novel KMT2C::CREB3L2 fusion and RARA/RXRA-mediated sensitivity to all-trans retinoic aci

Author:Ma, Lina; Wu, Min

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06983-5

4
Latent iron deficiency as a silent driver of donor attrition in high-frequency plateletpheresis donors: a longitudinal cohort stud

Author:Jin, Liqin; Zhang, Bin; Shen, Ying; Wang, Zilin; Wu, Weiguo; Chen, Zhihua; Wu, Xinhan

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06992-4

5
Real-world effectiveness of zanubrutinib plus salvage chemotherapy in relapsed or refractory double-expressor DLBC

Author:Lu, Jinbo; Zhang, Yujie; Ye, Xuan; Shi, Jingru; Lin, Qiuyan; Li, Ran; Du, Xinyi; Cao, Lei; Tian, Tian; Wang, Jvjuan; Xia, Yi; Liu, Hailing; Cheng, Yuexin; Fan, Lei; Shen, Haorui; Wang, Sanmei

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06974-6

6
Artificial intelligence reshaping the paradigm of hematologic malignancy diagnosis and treatment: From static assessment to dynamic precision managemen

Author:Li, Zhujin; Zhao, Jie; Huang, Lifang; Chen, Xiuhua; Wei, Jia; Tian, Weiwei

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06996-0

7
Treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with multiple myeloma: longer follow-up of the real-world MMY4032 stud

Author:Yang, Wei; Wang, Luqun; Wang, Yafei; Niu, Ting; Fu, Rong; Zhong, Yuping; Qian, Wenbin; Ding, Kaiyang; Sun, Kai; Liu, Hong; Fang, Baijun; Liu, Hui; Li, Yanhui; Yang, Yishen; Zhuo, Jianmin; Chen, Xi; Xun, Bijie; Lu, Jin

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06972-8

8
A case report of congenital sideroblastic anemia caused by a novel ALAS2 mutation in conjunction with thalassemi

Author:Chen, Zhi-Xiao; Yang, Li-Ye; Wang, Liang-Tuo; Chen, Bao-Ying; Liang, Jian-Lian; Liu, Li-Li; Yu, Xiao-Hua

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06984-4

9
A rare case of POEMS syndrome with unique endoscopic presentatio

Author:Zhou, Jing-kai; Zhang, Zhi-lin; Ding, Feng; Fang, Jun; Wang, Xiao-bing; Zhang, Meng; Ye, Mei

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06991-5

10
First clinical and molecular characterization of two rare complex β-globin variants in Chinese population using third generation sequencin

Author:Zhang, Lixian; Zhuang, Jianlong; Huang, Nan; Fu, Wanyu; Chen, Chunnuan

Journal: ANNALS OF HEMATOLOGY. 2026; Vol. 105, Issue 5, pp. -. DOI: 10.1007/s00277-026-06997-z


在线咨询

Annals Of Hematology

国际简称:ANN HEMATOL参考译名:血液学年鉴

年发文量:524 CiteScore:3.3 是否预警:否 Gold OA文章占比:57.23% 研究类文章占比:90.65%

杂志社联系方式:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Annals Of Hematology